1/8 🧵 How do HER2+ breast cancers escape targeted therapies?
A groundbreaking paper in @CancerDiscovery led by Roberto Würth, Andreas Trumpp, and colleagues at @hi_stem_lab reveals a new route of treatment resistance: Neuroendocrine Differentiation (NED) 🧬👇
A groundbreaking paper in @CancerDiscovery led by Roberto Würth, Andreas Trumpp, and colleagues at @hi_stem_lab reveals a new route of treatment resistance: Neuroendocrine Differentiation (NED) 🧬👇